维普期刊资源整合服务平台（V6.5）

136篇 您的检索式：作者名="Frystyk j"

选中清除导出查看参考文献查看引证文献引用追踪共7页首页上一页第1页下一页末页 /7 跳转

	题名	作者	年代	出处	被引量
1	Serum adiponection predicts all-cause mortality and end stage renal disease in patients with type 1 diabetes and diabetic nephropathy显示文摘	Jorsal A Tarnow L Frystyk J	2008	Kidney lnt2008，74，5：	1
2	The development of microalbuminuria is associated with raised longitudinal adiponectin levels in female but not male adolescent patients with type 1 diabetes显示文摘	Amin R Frystyk J Ong K		0，，：	1
3	Progression of diabetic retinopathy during improved metabolic control may be treated with reduced insulin dosage and/or somatostatin analogue administration-a case report显示文摘	Chantelau E Frystyk J	2005	Growth Hormone & IGF Research2005，15，2：	1
4	Short-term, low- dose GH therapy improves insulin sensitivity without modifying cortisol metabolism and ectopic fat accumulation in adults with GH deficiency显示文摘	Yuen KC Roberts CT Jr Frystyk J	2014	J Clin Endocrinol Metab2014，99，10：	1
5	Serum adiponectin is a predictor of coronary heart disease:a population based 10-yesr follow up study in elderly men显示文摘	Frystyk J Berne C Berglund L	2007	JCEM2007，49，：	1
6	Serum adiponectin is a predictor of coronary heart disease:A population-based 10-year follow-up study in elderly men显示文摘	Frystyk J Berne C Berglund L	2007	J Clin Endocrinol Metab2007，92，2：	1
7	Zethelius serum adiponectin is a predictor of coronary heart disease: A population based 10-year follow-up study in elderly men 显示文摘	Frystyk J Berne C Berglund L	2007	Clin Endocrinol Metab2007，92，：	1
8	Cardliovascular disease and insulin-like growth factor 1 显示文摘	Frystyk J Ledet T Moller N	2002	Circulation2002，106，8：	1
9	Increased serum adiponectin levels in type 1 diabetic patients with mierovascular complications 显示文摘	Frystyk J Tarnow L Krarup H T	2005	Diabetologia2005，48，9：	1
10	Early elective insulin therapy can reduce hyperglycemia and increase insulin-like growth factor-1 levels in very low birth weight infants显示文摘	Beardsall K Ogilvy-Stuart AL Frystyk J	2007	J Pediatr2007，151，6：	1
11	Obesity and cancer risk: the role of the insulin-IGF axis 显示文摘	Renehan AG Frystyk J Flyvbjerg A	2006	Trends Endocrinol Metab2006，17，：	1
12	Kidney IGF-1 and renal hypertrophy in GH deficient dwarf rats显示文摘	Flyvbjerg A Frystyk J фsterby R	1992	Am J Physiol1992，262，：	1
13	Obesity and cancer risk: therole of the insulin-IGF axis显示文摘	Renehan AG Frystyk J Flyvbjerg A	2006	Trends Endocrinol Metab2006，17，8：	1
14	Serum adiponectin is a predictor of coronary heart disease: a population based 10 year followup study in elderly- men显示文摘	FRYSTYK J BERNE C BERGLUND L	2007	J Clin Endocrinol Metab2007，92，：	1
15	Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very tow growth hormone (GH) dose in adults with severe GH deficiency显示文摘	Yuen KC Frystyk J White DK	2005	Clin Endocrinol (Oxf)2005，63，4：	1
16	Serum adiponectin is a predictor of coronary heart disease: a population-base 10 year follow-up study in elderly men 显示文摘	Frystyk J Beme C Berglund L	2007	J Clin Endocrinol Metab2007，92，2：	1
17	Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure显示文摘	Frystyk J Ivarsen P Skjaerbaek C	1999	Kidney Int1999，56，6：	1
18	Insulin-like growth factor-I serum concentrations and patterns of insulin-like growth factor binding proteins in patients with chronic liver disease显示文摘	SCHARF JG SCHMITZ F FRYSTYK J	1996	J Hepatol1996，25，5：	1
19	Cardiovascular disease and insulin-like growth factor Ⅰ显示文摘	FRYSTYK J LEDET T MOLLER N	2002	Circulatiun2002，106，8：	1
20	Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications显示文摘	Frystyk J Tarnow L Hansen TK		0，，：	1

返回顶部每页显示：

共7页首页上一页第1页下一页末页 /7 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示